deltatrials
Terminated PHASE2 INTERVENTIONAL 1-arm NCT02317783

Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment

Sponsor: University of Utah

Conditions Breast Cancer
Interventions Functional Magnetic Resonance Imaging (fMRI) [18F]Flutemetamol [18F]fluoro-2-deoxy-D-glucose (FDG)
Updated 17 times since 2017 Last updated: Oct 28, 2024 Started: Jan 31, 2018 Primary completion: Sep 24, 2019 Completion: Sep 24, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Enrollment challenges

Other terminated trials from University of Utah

See all terminations from University of Utah

Other Breast Cancer trials with similar outcome

Browse all Breast Cancer trials

A PHASE2 clinical study on Breast Cancer, this trial is terminated or withdrawn. The trial is conducted by University of Utah and has accumulated 17 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~May 2019 · 11 months · monthly snapshot~May 2019 – ~Apr 2020 · 11 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Apr 2021 · 31 days · monthly snapshot~Apr 2021 – ~Oct 2021 · 6 months · monthly snapshot~Oct 2021 – ~Feb 2022 · 4 months · monthly snapshot~Feb 2022 – ~Mar 2022 · 28 days · monthly snapshot~Mar 2022 – ~Mar 2023 · 12 months · monthly snapshot~Mar 2023 – ~Sep 2023 · 6 months · monthly snapshot~Sep 2023 – ~May 2024 · 8 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – present · 19 months · monthly snapshot

Change History

17 versions recorded

  1. Dec 2024 — Present [monthly]

    Terminated PHASE2

    Status: Active Not Recruiting → Terminated

  2. Sep 2024 — Dec 2024 [monthly]

    Active Not Recruiting PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE2

  4. May 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE2

  5. Sep 2023 — May 2024 [monthly]

    Active Not Recruiting PHASE2

    Status: Recruiting → Active Not Recruiting

▶ Show 12 earlier versions

  1. Mar 2023 — Sep 2023 [monthly]

    Recruiting PHASE2

  2. Mar 2022 — Mar 2023 [monthly]

    Recruiting PHASE2

  3. Feb 2022 — Mar 2022 [monthly]

    Recruiting PHASE2

  4. Oct 2021 — Feb 2022 [monthly]

    Recruiting PHASE2

    Phase: NA → PHASE2

  5. Apr 2021 — Oct 2021 [monthly]

    Recruiting NA

  6. Mar 2021 — Apr 2021 [monthly]

    Recruiting NA

  7. Jan 2021 — Mar 2021 [monthly]

    Recruiting NA

  8. Apr 2020 — Jan 2021 [monthly]

    Recruiting NA

  9. May 2019 — Apr 2020 [monthly]

    Recruiting NA

  10. Jun 2018 — May 2019 [monthly]

    Recruiting NA

  11. Feb 2017 — Jun 2018 [monthly]

    Recruiting NA

  12. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Utah
Data source: University of Utah

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations